Peak expiratory flow rate (PEFR) monitoring is often used alone in evaluating bronchial caliber and the response to a bronchodilator in the assessment of asthmatic subjects. A 15% change in airway caliber has been proposed as the criteria for modifying treatment. Our aim was to determine if changes in PEFR from one visit to the next can adequately evaluate changes in airway caliber as assessed by FEVY, which is considered the gold standard, and to identify the characteristics of subjects whose evaluations were inadequate. This was a retrospective study of 197 asthmatic subjects seen regularly at an outpatient clinic for whom FEVY and PEFR assessments, prebronchodilator and postbronchodilator, were available for two visits. There was a high correlation between PEFR and FEV1 (in absolute value or percent predicted) (r=0.83 and r=0.75). However, 24 of 56 (43%0) of those who had a change in FEV1 of 15% or more between two visits (mean change
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[%] ± SD, range [best-lowest/best]=20.9 ± 5.1%,0 15 to 36%) showed changes in PEFR of less than 15% (6.7 ± 6.5%, 8.0 to 13.9%). On the other hand, 14 of 42 (33%) subjects with changes in FEV1 of less than 15%7 bjective assessment of airway caliber based on forced expiratory volume in 1 s (FEV1) and peak expiratory flow rates (PEFR) is a relevant and important aspect in the assessment of asthmatic subjects as reviewed recently by Cross and Nelson1 and by Lebowitz.2 The widespread use of peak flowmeters in the screening and follow-up of subjects with reversible airway obstruction has been advocated since the early 1970s as a reliable method for evaluating airway caliber. This was based on several reports of a strong correlation between FEV1 and PEFR in cross-sectional analyses of subjects with asthma, with correlation coefficients ranging from 0.82 to 0.89.3-8 Furthermore, PEFR Thus, the objectives were to determine the sensitivity of changes in PEFR from one visit to the next to detect changes in airway caliber against the gold standard, FEV1, in asthmatic adults seen regularly at our outpatient clinic. We hypothesized that a large proportion of subjects would have a significant deterioration in their spirometry not detected by changes in PEFR.
METHODS

Subjects
Subjects were selected from a population of 303 patients who had been seen by two of us (J.L.M., A.C.) at least twice at the asthma outpatient clinic of the tertiary care Sacr&-Coeur Hospital, over a 2-year period between 1990 and 1992, and for whom FEV, and PEFR data had been collected. Entry criteria for the study group were as follows: (1) 
RESULTS
Baseline Results
Detailed demographic, personal, and clinical characteristics are shown in Table 1 . Our study population of 197 subjects had a higher proportion of women (58%) than men (42%). Very few subjects were current smokers at the time of the study. Most were atopic. Almost all of them had a diagnosis of asthma; only six (3.0%) subjects had asthma associated with chronic obstructive lung disease. Most subjects were using an inhaled f32-adrenergic agent together with an inhaled steroid, with or without theophylline. In most subjects (83%), their asthma had been well controlled on at least one occasion. When the best-achieved value for FEV1 at one or other visit was considered in comparison with the corresponding PEFR, there was a high and significant correlation in absolute values (r=0.83, p<0.001) (Fig 1, left) . Results were similar when values were expressed as percentages of predicted values (r=0.75, p<0.001) (Fig 1, right) The percent changes in FEV1 and the corresponding PEFR before inhalation of a bronchodilator from one visit to the next were strongly correlated (r=0.65, p<0.001) (Fig 2) . As shown in this figure, four groups of subjects were defined according to their coordinates with respect to the two perpendicular axes, indicating a 15% change in FEV1 and PEFR from one visit to the next. Group 1 included 131 subjects in whom the percent change in both FEV1 and PEFR from one visit to the next was lower than 15%, reflecting concordance between the changes assessed by the two measurements. Similarly, there was concordance for the 28 subjects in group 3 in whom (Table 3) . Overall, the mean percent change in FEV1 (11.3%) was greater than the mean percent change in the corresponding PEFR (8.3%) p<0.001). Among group 1 subjects, there was a concordance between measurements on the basis of the 15% cut-off line, but the difference in changes of corresponding measurements was also significant (p<0.001). Large and significant discrepancies were seen between the percent changes in FEV1 and the corresponding PEFR in groups 2 and 4.
In the comparison of the three cut-off points considered for PEFR changes to assess a 15% change in FEV1 from one visit to the next (Table 4) , the criteria of 60 L/min for absolute changes in PEFR showed the highest sensitivity but the least specificity; it also showed a higher negative predictive value than the 15% criteria, but the difference was small. The criteria of 15% for relative changes in PEFR maximized both sensitivity and specificity on the one hand, and both positive and negative predictive values on the other hand. FEV1 and PEFR Three possible explanations for the discrepancies between the percent changes in FEV1 and the corresponding PEFR between visits were examined separately. These included the status of asthma, the best achieved FEV1 and PEFR, and the concordance between corresponding changes in PEFR and FEVy in response to a bronchodilator. *Allocation of a patient to group 1, 2, 3, or 4 was determined by his position relative to the perpendicular axes on Figure 2 ; similarly, allocation to group lp, 2p, 3p, or 4p was determined by the position relative to the axes on Figure 3 .
Determinants of the Discrepancies in Changes in
The control status was similar (p=0.07) for groups 2 and 3, with a higher proportion of subjects (54.2% and 46.4%) being controlled on one occasion only (not illustrated). Among group 4 subjects, no particular control status was detected as the 14 subjects were almost equally distributed among the three defined control status groups (five well-controlled on two occasions, four well-controlled on one occasion, and five never well-controlled). Most subjects (52%) in group 1 were well-controlled on both visits.
The mean best-achieved prebronchodilator FEV1 (Table 5) were defined on the basis of the subject's position relative to the perpendicular axes drawn through the 15% cut-off points on the abscissa and the ordinate in Figure 3 where the maximum percent change in FEV, was plotted against its corresponding PEFR (189 subjects had complete data). The results of this study show that the percent change in FEV, is more marked than the corresponding percent change in PEFR in asthmatic subjects being followed up at a respiratory outpatient clinic. The relationship between these two measurements was assessed using correlation coefficients, but since this method may be misleading,20 we also used agreement analysis and graphic techniques. As recently reviewed by Cross The data used in this study were retrospective and this could be a potential source of bias. As far as dependent variables are concerned, they are objective measurements of airway caliber that should not be affected by the retrospective design of the study. The maneuvers were performed using the same equipment throughout the study. As far as independent variables are concerned, only the assessment of asthma control could be biased (as discussed above). The quality of the measuring devices could have been influenced by the long duration of the study, especially for the peak flowmeter (Mini-Wright), which has been shown by Shapiro and collaborators23 to deteriorate over a 2-year period. However, the accuracy of the PEFR monitoring was regularly checked by measuring the PEFR of control technicians for reproducible values; the spirometer (Vitalograph) was regularly calibrated using ATS standards. '4 Our subjects were followed up by chest physicians and they do not represent the population of asthmatics followed up by general practitioners who usually see less severely affected subjects. Generalizing our results should be done with caution.
The PEFR is widely used in other settings such as emergency departments24 and home monitoring. 25 The results of this study cannot be directly applied to these situations. In the emergency department, airway obstruction is often more severe. Although PEFR monitoring has been described as a useful procedure in assessing the possibility of discharging patients from hospital, it can wrongly assess airway caliber. The use of a peak flowmeter at home to alter treatment has been advocated for economic and practical reasons. Our findings suggest that PEFR assessment could be misleading in this situation by either underestimating or overestimating FEV, changes. Indeed, if a patient had been given strict instructions not to alter his or her treatment if PEFR had not changed by more than 15 or 20% even in the presence of worsening symptoms, it is clear that this could lead to a deterioration in asthma due to a delay in altering treatment. However, in outpatient clinics and at home, other considerations are taken into account before changing treatment (eg, need for medication, weather conditions, and exercise before assessment). Inexpensive portable spirometers are now available. These devices measure FEV, (in addition to PEFR) and may offer a way to monitor FEV, at home. We are not certain, however, that CHEST / 106 / 5 / NOVEMBER, 1994 1425 patients can reliably measure FEV1 at home without supervision. A study comparing PEFR and FEV1 home monitoring is currently being planned by our clinic.
This study shows that significant changes in FEV1 without accompanying significant changes in PEFR (and vice-versa) are not uncommon in asthmatic subjects. We did not address the question as to whether changes in FEV1 and/or PEFR can modify a clinician's decision to alter medication. A prospective study should be conducted in which assessment of control of asthma and treatment modification would be done blindly as to the lung function parameters. The physician's decisions would be reevaluated after taking PEFR and FEV1 results into account in alternate order during successive visits. Such studies should be carried out on a populationbased sample of asthmatic subjects followed up at a specialized clinic and asthmatic subjects followed up by general practitioners.
